Journal articles on the topic 'Oral tolerance'

To see the other types of publications on this topic, follow the link: Oral tolerance.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Oral tolerance.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Faria, Ana M. C., and Howard L. Weiner. "Oral tolerance." Immunological Reviews 206, no. 1 (August 2005): 232–59. http://dx.doi.org/10.1111/j.0105-2896.2005.00280.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

SMITH, K. M., A. D. EATON, L. M. FINLAYSON, and P. GARSIDE. "Oral Tolerance." American Journal of Respiratory and Critical Care Medicine 162, supplement_3 (October 2000): S175—S178. http://dx.doi.org/10.1164/ajrccm.162.supplement_3.15tac7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Weiner, Howard L., Andre Pires da Cunha, Francisco Quintana, and Henry Wu. "Oral tolerance." Immunological Reviews 241, no. 1 (April 13, 2011): 241–59. http://dx.doi.org/10.1111/j.1600-065x.2011.01017.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Weiner, H. L. "Oral tolerance." Proceedings of the National Academy of Sciences 91, no. 23 (November 8, 1994): 10762–65. http://dx.doi.org/10.1073/pnas.91.23.10762.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wu, Henry Yim, and Howard L. Weiner. "Oral Tolerance." Immunologic Research 28, no. 3 (2003): 265–84. http://dx.doi.org/10.1385/ir:28:3:265.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Garside, P., and A. McI Mowat. "Oral tolerance." Seminars in Immunology 13, no. 3 (June 2001): 177–85. http://dx.doi.org/10.1006/smim.2001.0310.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Moreau, Caroline, James Trussell, Fabien Gilbert, Nathalie Bajos, and Jean Bouyer. "Oral Contraceptive Tolerance." Obstetrics & Gynecology 109, no. 6 (June 2007): 1277–85. http://dx.doi.org/10.1097/01.aog.0000260956.61835.6d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Garside, Paul, and Allan Mcl Mowat. "Mechanisms of Oral Tolerance." Critical Reviews™ in Immunology 17, no. 2 (1997): 119–37. http://dx.doi.org/10.1615/critrevimmunol.v17.i2.10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Eiks, M. L. "Oral Glucose Tolerance Tests." Diabetes Care 19, no. 3 (March 1, 1996): 271. http://dx.doi.org/10.2337/diacare.19.3.271a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Margalit, Maya, and Yaron Ilan. "Oral Tolerance for IBD." American Journal of Gastroenterology 101, no. 12 (December 2006): 2890–91. http://dx.doi.org/10.1111/j.1572-0241.2006.00867_9.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

GARSIDE, P., A. McI MOWAT, and A. KHORUTS. "Oral tolerance in disease." Gut 44, no. 1 (January 1, 1999): 137–42. http://dx.doi.org/10.1136/gut.44.1.137.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Hamad, Ahmad, and Wesley Burks. "Oral tolerance and allergy." Seminars in Immunology 30 (April 2017): 28–35. http://dx.doi.org/10.1016/j.smim.2017.07.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Commins, Scott P. "Mechanisms of Oral Tolerance." Pediatric Clinics of North America 62, no. 6 (December 2015): 1523–29. http://dx.doi.org/10.1016/j.pcl.2015.07.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Greenspoon, Jeffrey S. "Oral Glucose Tolerance Test." Mayo Clinic Proceedings 63, no. 8 (August 1988): 838. http://dx.doi.org/10.1016/s0025-6196(12)62371-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Tordesillas, Leticia, and M. Cecilia Berin. "Mechanisms of Oral Tolerance." Clinical Reviews in Allergy & Immunology 55, no. 2 (February 27, 2018): 107–17. http://dx.doi.org/10.1007/s12016-018-8680-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Stanley, Steve. "Oral tolerance of food." Current Allergy and Asthma Reports 2, no. 1 (January 2002): 73–77. http://dx.doi.org/10.1007/s11882-002-0043-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Nguyen, Nhan H., Vincent Chak, Katherine Keller, Helen Wu, and Sathy V. Balu-Iyer. "Phosphatidylserine-mediated oral tolerance." Cellular Immunology 384 (February 2023): 104660. http://dx.doi.org/10.1016/j.cellimm.2022.104660.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Chung, Yeonseok, Sun-Young Chang, and Chang-Yuil Kang. "Kinetic Analysis of Oral Tolerance: Memory Lymphocytes Are Refractory to Oral Tolerance." Journal of Immunology 163, no. 7 (October 1, 1999): 3692–98. http://dx.doi.org/10.4049/jimmunol.163.7.3692.

Full text
Abstract:
Abstract Oral administration of soluble Ag before immunization induces peripheral tolerance and is effective in suppressing animal models of autoimmune diseases. Although tolerance induction in primed animals is more clinically relevant, it is not well studied. Therefore, this study was designed to examine the feeding effects on different phases of the immune response. We observed that feeding a single high dose (250 mg) of OVA to OVA-primed BALB/c mice could induce OVA-specific suppression in the Ab production and T cell proliferation only at the naive and the activation phases of the immune response, whereas multiple high doses (100 mg/feed for 10 days) were effective at the effector phase. OVA-specific IL-4 production in culture supernatant was also suppressed in the tolerized groups. However, when the mice had resting memory lymphocytes, even multiple feeding regimens were not effective in tolerance induction, although multiple low doses (1 mg/feed for 10 days) partially suppressed Ab production. This phenomenon was confirmed by adoptive transfer study. Nevertheless, the reactivated memory response was suppressed partially by multiple high doses. Our findings have an important implication for understanding the mechanism of oral tolerance and for the therapeutic applications of oral tolerance to autoimmune diseases.
APA, Harvard, Vancouver, ISO, and other styles
19

Rodríguez-Alvarez, M., M. Fernandez-Rivas, T. Robledo Echarren, and C. Martinez-Cócera. "Persistence of Tolerance After Specific Oral Tolerance Induction." Journal of Allergy and Clinical Immunology 125, no. 2 (February 2010): AB22. http://dx.doi.org/10.1016/j.jaci.2009.12.118.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Kurihara, Kazuyuki. "Weaning considering oral tolerance induction." Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology 30, no. 1 (2016): 13–20. http://dx.doi.org/10.3388/jspaci.30.13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Rezende, Rafael M., and Howard L. Weiner. "Oral tolerance: an updated review." Immunology Letters 245 (May 2022): 29–37. http://dx.doi.org/10.1016/j.imlet.2022.03.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Whitacre, Caroline C. "New insights into oral tolerance." Gastroenterology 119, no. 1 (July 2000): 260–62. http://dx.doi.org/10.1053/gast.2000.9192.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Holbrook, W. P., D. Olafsdottir, H. B. Magnusson, and E. Benediktsdottir. "Penicillin tolerance among oral streptococci." Journal of Medical Microbiology 27, no. 1 (September 1, 1988): 17–22. http://dx.doi.org/10.1099/00222615-27-1-17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Wang, Jun, and Rene EM Toes. "Mechanisms of oral tolerance revisited." Arthritis Research & Therapy 10, no. 2 (2008): 108. http://dx.doi.org/10.1186/ar2402.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Ake-Uzoigwe, Rukeme, Anubha Arora, Dongping Zhang, Carolyn Salafia, Kolawole Akinnawonu, and Aleksandr Fuks. "Postpartum Oral Glucose Tolerance Test." Obstetrics & Gynecology 129 (May 2017): 40S—41S. http://dx.doi.org/10.1097/01.aog.0000514347.83223.e8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

McSorley, Stephen J., and Paul Garside. "Vaccination by inducing oral tolerance?" Immunology Today 20, no. 12 (December 1999): 555–60. http://dx.doi.org/10.1016/s0167-5699(99)01539-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Meyer, Tim, Reiner Ullrich, and Martin Zeitz. "Oral tolerance induction in humans." Experimental and Molecular Pathology 93, no. 3 (December 2012): 449–54. http://dx.doi.org/10.1016/j.yexmp.2012.10.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Weiner, Howard L. "Oral Tolerance: Mobilizing the Gut." Hospital Practice 30, no. 9 (September 15, 1995): 53–58. http://dx.doi.org/10.1080/21548331.1995.11443258.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

DRACHMAN, DANIEL B., SEIICHI OKUMURA, ROBERT N. ADAMS, and KEVIN R. McINTOSH. "Oral Tolerance in Myasthenia Gravisa." Annals of the New York Academy of Sciences 778, no. 1 (February 1996): 258–72. http://dx.doi.org/10.1111/j.1749-6632.1996.tb21134.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

GIENAPP, INGRID, KAREN COX, NAJMA JAVED, and CAROLINE WHITACRE. "Oral Tolerance in Autoimmune Encephalomyelitis." Annals of the New York Academy of Sciences 778, no. 1 (February 1996): 382–83. http://dx.doi.org/10.1111/j.1749-6632.1996.tb21150.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

VAZ, N., A. M. C. FARIA, B. A. VERDOLIN, and C. R. CARVALHO. "Immaturity, Ageing and Oral Tolerance." Scandinavian Journal of Immunology 46, no. 3 (September 1997): 225–29. http://dx.doi.org/10.1046/j.1365-3083.1997.d01-117.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

STAINES, N. A. "Oral Tolerance and Collagen Arthritis." Rheumatology 31, no. 4 (1992): 283–84. http://dx.doi.org/10.1093/rheumatology/31.4.283.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Pabst, O., and A. M. Mowat. "Oral tolerance to food protein." Mucosal Immunology 5, no. 3 (February 8, 2012): 232–39. http://dx.doi.org/10.1038/mi.2012.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Mayer, Lloyd, and Ling Shao. "Therapeutic potential of oral tolerance." Nature Reviews Immunology 4, no. 6 (June 2004): 407–19. http://dx.doi.org/10.1038/nri1370.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Strobel, St, and Anne Ferguson. "Oral Tolerance - Induction and Modulation*." Klinische Pädiatrie 197, no. 04 (July 1985): 297–301. http://dx.doi.org/10.1055/s-2008-1033987.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Telemo, Esbjörn, Malin Karlsson, Anna Dahlman-Höglund, Ulf Dahlgren, and Samuel Lundin. "Oral Tolerance in Experimental Animals." International Archives of Allergy and Immunology 113, no. 1-3 (1997): 219–23. http://dx.doi.org/10.1159/000237552.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Mayer, Lloyd, Kirk Sperber, Lisa Chan, Joseph Child, and Lisa Toy. "Oral tolerance to protein antigens." Allergy 56, s67 (April 2001): 12–15. http://dx.doi.org/10.1111/j.1398-9995.2001.00904.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Hohlstein, Leigh Anne, Harry E. Gwirtsman, Frank Whalen, and Melvin P. Enns. "Oral glucose tolerance in bulimia." International Journal of Eating Disorders 5, no. 1 (January 1986): 157–60. http://dx.doi.org/10.1002/1098-108x(198601)5:1<157::aid-eat2260050116>3.0.co;2-g.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Lipkowski, A. W., B. Baranowska, E. Marczak, B. Kwiatkowska-Patzer, B. Gajkowska, and M. Walski. "Protein hydrolysates for oral tolerance." BioFactors 12, no. 1-4 (2000): 147–50. http://dx.doi.org/10.1002/biof.5520120123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Wambre, Erik, and David Jeong. "Oral Tolerance Development and Maintenance." Immunology and Allergy Clinics of North America 38, no. 1 (February 2018): 27–37. http://dx.doi.org/10.1016/j.iac.2017.09.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Veldhoen, Marc. "Oral tolerance: Passing CD11b on the way to tolerance." Immunology & Cell Biology 85, no. 6 (July 24, 2007): 397–98. http://dx.doi.org/10.1038/sj.icb.7100106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Winkelhoff, A. J., T. J. M. Steenbergen, and J. Graaff. "Oxygen tolerance of oral and non-oral black-pigmentedBacteroidesspecies." FEMS Microbiology Letters 33, no. 2-3 (February 1986): 215–18. http://dx.doi.org/10.1111/j.1574-6968.1986.tb01274.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Kadono, Takafumi, Hanako Ohmatsu, and Shinichi Sato. "Beta 7 integrin is essential for the induction of oral tolerance (112.15)." Journal of Immunology 186, no. 1_Supplement (April 1, 2011): 112.15. http://dx.doi.org/10.4049/jimmunol.186.supp.112.15.

Full text
Abstract:
Abstract Oral tolerance is one of the hallmarks of intestinal immunity that induces systemic unresponsiveness to orally ingested antigens. Beta 7 integrin is known to mediate lymphocyte migration to gut-associated lymphoid tissues, especially Peyer’s patches. We assume that lack of beta 7 integrin might affect oral tolerance due to defective lymphocyte migration to intestinal tissues. When mice were intraperitoneally immunized with OVA following oral OVA administration, beta 7 integrin deficient mice showed defective oral tolerance measured by OVA-specific IgG and IgM antibody titers, numbers of OVA-specific antibody forming cells, and proliferative responses to OVA. Oral tolerance in L-selectin deficient mice was unimpaired. Moreover, beta 7 integrin/ L-selectin double deficient mice showed defective oral tolerance to a similar degree as beta 7 integrin deficient mice, suggesting no additive effect of L-selectin deficienty. We also measured cytokine secretion from splenocytes following oral tolerance induction and found that whereas IFN gamma secretion was decreased in wild-type mice, this reduction was abrogated in beta 7 deficient mice. These results demonstrate that beta 7 integrin is essential for oral tolerance.
APA, Harvard, Vancouver, ISO, and other styles
44

Liu, Liming, Vijay K. Kuchroo, and Howard L. Weiner. "B7.2 (CD86) But Not B7.1 (CD80) Costimulation Is Required for the Induction of Low Dose Oral Tolerance." Journal of Immunology 163, no. 4 (August 15, 1999): 2284–90. http://dx.doi.org/10.4049/jimmunol.163.4.2284.

Full text
Abstract:
Abstract Oral administration of Ag leads to systemic unresponsiveness (oral tolerance) to the fed Ag. Oral tolerance is mediated through active suppression by Th2 or TGF-β-secreting cells or clonal anergy/deletion, depending on the Ag dose used, with low dose favoring active suppression and high dose favoring anergy/deletion. The nature of APC and inductive events leading to the generation of oral tolerance have not been well defined. To determine the role of costimulatory molecules in the induction of oral tolerance, we have tested the effect of anti-B7.1 or anti-B7.2 mAb on the induction of tolerance by both high and low dose Ag feeding regimens. Our results show that the B7.2 molecule is critical for the induction of low-dose oral tolerance. Injection of anti-B7.2 but not anti-B7.1 intact Ab or Fab fragments inhibited the oral tolerance induced by low-dose (0.5 mg) but not high-dose OVA (25 mg) feeding. In addition, anti-B7.2, but not anti-B7.1, inhibited secretion of TGF-β, one of the primary cytokines that mediates low-dose oral tolerance. Finally, in the in vivo model of experimental allergic encephalomyelitis, anti-B7.2 mAb treatment abrogated protection offered against disease by low-dose myelin basic protein feeding, while anti-B7.1 had no effect. Anti B7.2 had no effect on disease suppression by high-dose oral Ag. These data demonstrate that B7.2 costimulatory molecules play an essential role in the induction of low-dose oral tolerance.
APA, Harvard, Vancouver, ISO, and other styles
45

Shakya, Akhilesh Kumar, Buddhadev Mallick, and Kutty Selva Nandakumar. "A Perspective on Oral Immunotherapeutic Tools and Strategies for Autoimmune Disorders." Vaccines 11, no. 6 (May 27, 2023): 1031. http://dx.doi.org/10.3390/vaccines11061031.

Full text
Abstract:
Oral immune tolerance is a physiological process to achieve tolerance against autoimmunity by oral ingestion of self-antigen(s) or other therapeutics. At the cellular level, oral tolerance suppresses autoimmune diseases by activating FoxP-positive and -negative regulatory T cells (Tregs) and/or causing clonal anergy or deletion of autoreactive T cells, affecting B cell tolerance. However, oral delivery of antigens/biologics is challenging due to their instability in the harsh environment of the gastrointestinal (GI) tract. Several antigen/drug delivery tools and approaches, including micro/nanoparticles and transgenic plant-based delivery systems, have been explored to demonstrate oral immune tolerance for different autoimmune diseases successfully. However, despite the effectiveness, variation in results, dose optimization, and undesirable immune system activation are the limitations of the oral approach to further advancement. From this perspective, the current review discusses the oral tolerance phenomenon, cellular mechanisms, antigen delivery tools and strategies, and its challenges.
APA, Harvard, Vancouver, ISO, and other styles
46

Kurihara, Shunjiro, Kotaro Suzuki, Masaya Yokota, Takashi Ito, Yuki Hayashi, Ryo Kikuchi, Takahiro Kageyama, et al. "Eosinophils Contribute to Oral Tolerance via Induction of RORγt-Positive Antigen-Presenting Cells and RORγt-Positive Regulatory T Cells." Biomolecules 14, no. 1 (January 10, 2024): 89. http://dx.doi.org/10.3390/biom14010089.

Full text
Abstract:
Oral tolerance has been defined as the specific suppression of immune responses to an antigen by prior oral administration of the antigen. It has been thought to serve to suppress food allergy. Previous studies have shown that dendritic cells (DCs) and regulatory T cells (Tregs) are involved in the induction of oral tolerance. However, the detailed mechanisms of Treg induction in oral tolerance remain largely unknown. Eosinophils have been recognized as effector cells in allergic diseases, but in recent years, the diverse functions of tissue-resident eosinophils have been reported. Eosinophils in the intestine have been reported to induce Tregs by releasing TGF-β, but the role of eosinophils in oral tolerance is still controversial. In this study, we analyzed the roles of eosinophils in oral tolerance using eosinophil-deficient ΔdblGATA mice (mice lacking a high-affinity GATA-binding site in the GATA1 promoter). ΔdblGATA mice showed impaired antigen-induced oral tolerance compared to wild-type mice. The induction of RORγt+ Tregs in mesenteric lymph nodes (MLNs) by oral tolerance induction was impaired in ΔdblGATA mice compared to wild-type mice. An increase in RORγt+ antigen-presenting cells (APCs), which are involved in RORγt+ Treg differentiation, in the intestine and MLNs was not seen in ΔdblGATA mice. Notably, the expansion of group 3 innate lymphoid cells (ILC3s), a subset of RORγt+ APCs, by oral tolerance induction was seen in wild-type mice but not ΔdblGATA mice. These results suggest that eosinophils are crucial in the induction of oral tolerance, possibly via the induction of RORγt+ APCs and RORγt+ Tregs.
APA, Harvard, Vancouver, ISO, and other styles
47

abbas, sukardi. "Cultural Tolerance in Oral Literature Ternate." ISLLAC : Journal of Intensive Studies on Language, Literature, Art, and Culture 3, no. 1 (May 26, 2019): 111–17. http://dx.doi.org/10.17977/um006v3i12019p111.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Hachimura, Satoshi, and Shuichi Kaminogawa. "Oral tolerance and its clinical application." Japanese Journal of Clinical Immunology 22, no. 6 (1999): 466–68. http://dx.doi.org/10.2177/jsci.22.466.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Pelaez-Prestel, Hector F., Jose L. Sanchez-Trincado, Esther M. Lafuente, and Pedro A. Reche. "Immune Tolerance in the Oral Mucosa." International Journal of Molecular Sciences 22, no. 22 (November 10, 2021): 12149. http://dx.doi.org/10.3390/ijms222212149.

Full text
Abstract:
The oral mucosa is a site of intense immune activity, where a large variety of immune cells meet to provide a first line of defense against pathogenic organisms. Interestingly, the oral mucosa is exposed to a plethora of antigens from food and commensal bacteria that must be tolerated. The mechanisms that enable this tolerance are not yet fully defined. Many works have focused on active immune mechanisms involving dendritic and regulatory T cells. However, epithelial cells also make a major contribution to tolerance by influencing both innate and adaptive immunity. Therefore, the tolerogenic mechanisms concurring in the oral mucosa are intertwined. Here, we review them systematically, paying special attention to the role of oral epithelial cells.
APA, Harvard, Vancouver, ISO, and other styles
50

MOWAT, ALLAN McI, LUCY A. PARKER, HELEN BEACOCK-SHARP, Owain R. Millington, and FERNANDO CHIRDO. "Oral Tolerance: Overview and Historical Perspectives." Annals of the New York Academy of Sciences 1029, no. 1 (December 2004): 1–8. http://dx.doi.org/10.1196/annals.1309.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography